Article

Biosimilar Lawsuit Highlights AJPB Week in Review

Author(s):

Davy James, Managing Editor

Top articles of the week on The American Journal of Pharmacy Benefits.

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
Image Credit: © utah51 - stock.adobe.com
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Patient taking prescription medicine -- Image credit: Rawpixel.com | stock.adobe.com
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Related Content
Biosimilar, Crohn Disease, CT-P13 | Image Credit: Aliaksandr Marko - stock.adobe.com
October 22nd 2024

Study: Pharmacokinetics, Safety Comparable Between CT-P13 Autoinjector and Pre-Filled Syringe

Ashley Gallagher, Associate Editor
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Celebrating Unique Pharmacist Career Paths That Drive Innovation
October 21st 2024

Celebrating Unique Pharmacist Career Paths That Drive Innovation

Allison Arant
Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations
January 25th 2024

Season 3 - Public Health Matters: A Look at Wearable Technology, AI-Assisted Innovations

FDA logo -- Image credit: Araki Illustrations | stock.adobe.com
October 15th 2024

FDA Approves Imuldosa, Stelara Biosimilar For Treatment of Chronic Inflammatory Conditions

Gillian McGovern, Assistant Editor
Marilyn Bulloch Doing Rounds in a Hospital With Physicians
October 14th 2024

Pharmacy Times Launches Behind The Script Campaign to Highlight Pharmacists